Veltam 0.2 mg Tablet MR_INTAS

Veltam 0.2 Tablet MR functions as an alpha-adrenergic antagonist and is employed in the management of benign prostatic hyperplasia, addressing symptoms such as urinary difficulty. It should be noted that while it alleviates symptoms, it does not reduce prostate size.

Adherence to the prescribed dosage and duration is recommended for Veltam 0.2 Tablet MR. Consumption may occur with or without food, but consistency in timing is crucial. The tablet should be swallowed whole without crushing or chewing. Ceasing the medication without consulting a doctor may exacerbate symptoms, emphasizing the importance of completing the treatment course for optimal effectiveness.

Possible side effects include dizziness, back pain, chest pain, ejaculation disorder, and retrograde ejaculation. Consultation with a healthcare professional is essential if any side effects persist or become bothersome.

Implementing simple lifestyle adjustments can enhance symptom management. Promptly responding to the urge to urinate, avoiding straining during bladder emptying, and refraining from consuming caffeinated or alcoholic beverages before bedtime or outings are recommended practices.

Prior to commencing treatment, inform your doctor of any concurrent medications for other health conditions. If eye surgery for cataracts or glaucoma is anticipated, the eye doctor should be made aware of Veltam 0.2 Tablet MR usage. Patients with liver disease should exercise caution, undergo regular follow-ups as advised by their doctor, and communicate any concerns promptly.